Skip to main content
    G

    GRI Bio Inc. (GRI)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.34
    -0.06 (-4.29%)

    Market Cap: $3.06M

    Last updated: Nov 17, 2026 at 4:15 PM ET

    GRI Bio Inc. (GRI) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    GRI Bio (GRI) has a market cap of $3.06M. It holds $9.47M more cash than debt, 309.48% of its market cap. Revenue fell 100.00% over the last 12 months from the 12 months before.

    Total Valuation

    Market Cap$3.06M
    Latest price (Nov 17, 2026)$1.34

    Key Dates

    The next earnings report is expected on Feb 2, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateFeb 2, 2027 (expected)
    Last Earnings DateNov 13, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 21.12% in the quarter ended Sep 30, 2026.

    Shares Outstanding2.19M
    Shares Change (QoQ)+21.12%

    Price Statistics

    The stock is down 97.17% over 52 weeks and trades 22.09% below its 50-day average.

    Beta (1Y)0.63
    52-Week Change-97.17%
    1-Month Change-7.59%
    3-Month Change-22.54%
    6-Month Change-39.91%
    5-Year Change-100.00%
    Total Return (1Y)-97.17%
    Total Return (3Y CAGR)-96.94%
    Total Return (5Y CAGR)-95.28%
    Return vs SPY (1Y)-108.89%
    Max Drawdown (1Y)-97.76%
    Max Drawdown (3Y)-100.00%
    Sharpe Ratio (1Y)-2.48
    Correlation with SPY (1Y)0.06
    50-Day Average$1.72
    200-Day Average$2.03
    52-Week Range$1.36 to $64.12
    RSI (14 Days)39.4
    Average Volume (20 Days)48.90K

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 10.21x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio10.21x
    Quick Ratio10.21x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on equity is -88.63% and return on assets is -79.98% over the last 12 months.

    Return on Equity (ROE)-88.63%
    Return on Assets (ROA)-79.98%

    Scores

    GRI has a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.

    Piotroski F-Score2 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue was $0 over the last 12 months.

    Revenue$0
    Revenue Growth (YoY)-100.00%
    Gross Profit-$1.00K
    Operating Income-$7.83M
    Pretax Income-$7.81M
    Net Income-$7.81M
    Reported EPS (TTM)-$119.82

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 90.27% of the $9.76M in total assets.

    Cash and Equivalents$9.47M
    Total Debt$0
    Net Cash$9.47M
    Net Cash Per Share$4.33
    Working Capital$8.78M
    Shareholder Equity$8.81M
    Book Value Per Share$4.03
    Total Assets$9.76M
    Total Liabilities$953.00K

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow-$9.58M
    FCF Per Share-$4.38

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Dividends and Yields

    GRI does not pay a dividend.

    Buyback Yield-511.98%
    Shareholder Yield-511.98%

    Stock Splits

    The last split was a 1-for-28 reverse split on Jan 26, 2026.

    Last Split DateJan 26, 2026
    Split TypeReverse split
    Split Ratio1:28

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About GRI

    What is GRI's market cap?

    GRI Bio has a market cap of $3.06M.

    How many shares of GRI are outstanding?

    GRI Bio has 2.19M shares outstanding.

    Does GRI pay a dividend?

    No. GRI Bio does not pay a dividend.

    How much debt does GRI have?

    GRI Bio has $0 of total debt and $9.47M of cash and equivalents, a net cash position of $9.47M.